Cough syrup made in India and sold in The Gambia contained “unacceptable levels” of the toxins diethylene glycol (DEG) and ethylene glycol (EG), according to tests conducted by a Swiss laboratory. Samples of the syrup, made by Haryana-based Maiden Pharmaceuticals, were sent for analysis by The Gambian government as part of its investigation into an epidemic of Acute Kidney Injury (AKI), suspected to have killed at least 70 children in The Gambia between July and October 2022.